No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs187439643 |
chr19:53514614-53514615 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs1661965 |
chr19:53514687-53514688 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs36080416 |
chr19:53514775-53514776 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs112728324 |
chr19:53514821-53514822 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs191906327 |
chr19:53514850-53514851 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs558891423 |
chr19:53514862-53514863 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs577229767 |
chr19:53514898-53514899 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs1661964 |
chr19:53514904-53514905 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs563278640 |
chr19:53514969-53514970 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs115854033 |
chr19:53515001-53515002 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs146251289 |
chr19:53515044-53515045 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs550132931 |
chr19:53515096-53515097 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs373808013 |
chr19:53515110-53515111 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs115201830 |
chr19:53515223-53515224 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs548118853 |
chr19:53515255-53515256 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs534144522 |
chr19:53515265-53515266 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs142748110 |
chr19:53515266-53515267 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs34629444 |
chr19:53515290-53515291 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs577613474 |
chr19:53515297-53515298 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs539887304 |
chr19:53515326-53515327 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs182081314 |
chr19:53515344-53515345 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs186063486 |
chr19:53515405-53515406 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs537229158 |
chr19:53515407-53515408 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs145202691 |
chr19:53515460-53515461 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs369887848 |
chr19:53515462-53515463 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs370576197 |
chr19:53515510-53515511 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs555243812 |
chr19:53515540-53515541 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs573518828 |
chr19:53515547-53515548 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs147390260 |
chr19:53515548-53515549 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs552854694 |
chr19:53515553-53515554 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs577217429 |
chr19:53515557-53515558 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs577192605 |
chr19:53515606-53515607 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs563372068 |
chr19:53515653-53515654 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs369155779 |
chr19:53515677-53515678 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs112675672 |
chr19:53515678-53515679 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs575219710 |
chr19:53515694-53515695 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs542719835 |
chr19:53515752-53515753 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs556638340 |
chr19:53515764-53515765 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs562101826 |
chr19:53515765-53515766 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs529514317 |
chr19:53515773-53515774 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs111878710 |
chr19:53515777-53515778 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs182696673 |
chr19:53515811-53515812 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs560130265 |
chr19:53515833-53515834 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs73068774 |
chr19:53515842-53515843 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
45 |
rs551513081 |
chr19:53515857-53515858 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs570054390 |
chr19:53515867-53515868 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs8106572 |
chr19:53515886-53515887 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs148547435 |
chr19:53515975-53515976 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs567077949 |
chr19:53516015-53516016 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs141948399 |
chr19:53516067-53516068 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|